Jobs
View more job listings or post a job
Genentech Scientist/ Senior Scientist, Small Molecule Pharmaceutics 
Genentech Senior Scientific Researcher_Bioanalysis
Jazz Pharmaceuticals Associate Director, Early Development Pharmacologist
UC Davis - Equine Analytical Chemistry Program LC/MS CHEMIST - STAFF RESEARCH ASSOCIATE 3        
Genentech Associate Scientist/Scientist - Biotransformation, Drug Metabolism And Pharmacokinetics (DMPK)
UC Davis - Equine Analytical Chemistry Program LC/MS CONFIRMATION SUPERVISOR (LABORATORY RESEARCH SUPERVISOR 2)  
Jazz Pharmaceuticals Head of Toxicology
Dow Development Laboratories Formulation Chemist
Genentech Scientist, DMPK
Post a job

Workshop

Antibody Drug Conjugates: Chemistry, Biology, Pharmacokinetics and Toxicology


Speakers: Jagath Junutula (Cellerant), Andy Polson (Genentech) , Toni Kline (Sutro), Chetana Rao (BMS), Donglu Zhang (Genentech), Keyang Xu, PhD (Genentech), Melissa Schutten (Genentech)
Organizers: Thomas Pillow (Genentech)
Date: 2018-09-12
Time: 8:45-16:00 Pacific Time
Registration fee (USD): Regular: $195; For unemployed or students: $30; Academic: $125; For major-sponsor rep (incl lunch): $0; For vendor-show rep: $35
Location: SF Bay Area: Foster City Crowne Plaza
Major Sponsor: (2)Applied BioMath, LLC; Intertek
Vendor show vendors registered to date: (24)AIT Bioscience; Alturas Analytics; Applied StemCell, Inc.; Averica Discovery Services; BioPharmEquip; Bruker; JOINN Labs; KCAS Bioanalytical & Biomarker Services; MabPlex; Medpace; MicroConstants; Pacific BioLabs; PHARMout Laboratories; Promega; Q2 Solutions; QPS; SCIEX; Sekisui XenoTech, LLC; Selvita Inc.; Sepax Technologies; Shimadzu Scientific Instruments, Inc; Sigma Aldrich; SRI International; WuXi AppTec
Registration: http://www.PBSS.org
Registration deadline:2018-09-11  (it will close sooner if the seating cap is reached)

About the Topic

Linking a small-molecule cytotoxic drug to a monoclonal antibody takes the strengths of both while potentially mitigating the liabilities. The resulting bioconjugates, known as antibody−drug conjugates or ADCs, have been validated clinically, with four approved anti-cancer agents for solid and hematological cancers. This workshop will broadly discuss the strategies for designing, constructing and analyzing ADCs utilizing the latest advances in the field.

This workshop will cover the following specific topics:

  • Overview of antibody-drug conjugates (ADCs) and clinical progress
  • Selecting a target for ADCs
  • The chemistry of linkers and drugs
  • Site-specific conjugation
  • Analytical characterization of ADCs
  • ADC bioanalysis & pharmacokinetics
  • Preclinical safety/toxicology

Workshop Agenda: 

Time Topic  Presenter
8:45-9:00 Welcome and Introduction Thomas Pillow
9:00-9:45 1. ADC Discovery & Development Jagath Junutula
9:45-10:30 2. ADCs for Hematological Malignancies Andy Polson
10:30-10:45 Break  
10:45-11:30 3. Conjugation Modalities for ADC Generation Chetana Rao
11:30-12:30 Lunch  
12:30-1:15 4. ADC Chemistry Toni Kline
1:15-2:00 5. Small Molecule DMPK for ADCs Donglu Zhang
2:00-2:15 Break  
2:15-3:00 6. Bioanalysis of ADCs   Keyang Xu
3:00-3:45 7. ADC Safety/Toxicity Melissa Schutten
3:45-4:15 Panel Discussion All
4:15-4:30 Final Remarks Thomas Pillow

 


2019-09-13, Biotransformation and Disposition of Larger Molecules: Peptides, Nucleotides, Proteins, mAbs, and ADCs
2019-10-03, Small-Molecule Bioanalytical Method Validation & Regulated Bioanalysis: Fundamentals, the New FDA Guidance and Regulatory Trends
2019-10-18, Physiologically Based Pharmacokinetic (PBPK) Modeling: Fundamentals, Regulatory Guidance & Applications
2019-11-12, Antibody Drug Discovery and Development: Hit Generation, Engineering, Cell-line Development, IND enabling studies, and Biosimilars
2019-12-10, In Vitro Diagnostics, Companion Diagnostics and Precision Medicine
2020-01-21, Best Practices for Clinical Trial Design
2020-02-11, Drug-Device Combination
2020-02-24, Advanced LC-MS/MS (Day1) & Interpretation of MS/MS CID Spectra (Day2)
2020-05-12, Regulated Large Molecule Bioanalysis: Fundamentals, the New FDA Guidance and Beyond
2020-05-22, No More Undruggables: Unconventional Approaches for Drug Discovery and Design - prodrugs, PROTACS, fragment-based design, directed evolution and beyond
2020-06-23, Advances in Immuno-Oncology (A Joint Symposium by PBSS and BioScience Forum)
┬ęPharmaceutical & BioScience Society, International; Last Modified: 8/20/2019; Visited: 1232; Admin Logon
Ads (in random order)
Submit a Text Ad
($250 for 2 months)

UC Davis UC Davis LC/MS Confirmation Supervisor (Lab Rsch Supv 2) Apply Online: http://50.73.55.13/counter.php?id=165482 UC Davis is an AA/EOE
XCELERATE at Biotech Week Boston Driving the Future of the Life Science Industry. Sept. 11 at BCEC. Learn more.
BIOTECH WEEK BOSTON - Sept. 9-12 Access over 5,000 of the most innovative scientific minds & business leaders in Boston and around the world. Learn More.
Submit a Text Ad